Dr. Sheyla Gonzalez, MD

Dr. Gonzalez practices at Laboratory Corporation of America in Zephyrhills, Florida.

Dr. Gonzalez's NPI, 1457989451, was assigned on March 27, 2020. Dr. Gonzalez graduated from St. George's University School of Medicine in 2020. Dr. Gonzalez holds Florida license ME159338.

Dr. Gonzalez's primary practice is Laboratory Corporation of America, at 5611 St, Zephyrhills, FL 33542 in Pasco County. The practice phone is (800) 877-5227.

Dr. Gonzalez's primary practice is Laboratory Corporation of America in Zephyrhills, Florida. Dr. Gonzalez is also affiliated with Baptist Health Homestead Hospital. The medical group on file is First Docs. Dmand AI also links Dr. Gonzalez to 2 more medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gonzalez is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gonzalez is licensed in Florida.

CMS data shows 53 Medicare services from Dr. Gonzalez across 2 procedure codes in 2024, for 55 Medicare patients. Medicare paid $7,014 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 75 to 84, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 67% are also on Medicaid. Their average risk score is 4.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 65, with 57% women.

In 2024, Dr. Gonzalez wrote 2,569 Medicare Part D claims for 246 patients. 87% of them were for generic drugs. CMS names the drug for 1,979 of them, across 62 drugs with 11 or more claims each, at $55,489 in total drug cost. In 2022, CMS named 23 claims across 2 drugs.

Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Gonzalez, published from 2021 to 2024. 2021 was the busiest year, with 3. Dr. Gonzalez has published most often in Cureus. Dr. Gonzalez's most frequent co-authors are Shadi A. Baajour, MD, Ashley Hall and Stephanie Prater, MD.

CMS Open Payments shows 4 general payments to Dr. Gonzalez from 3 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $137.

Dr. Gonzalez graduated from St. George's University School of Medicine in 2020.

Dr. Gonzalez is in network with 3 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.